Every 10 minutes someone dies from an asthma attack. High FeNO, a marker of airway inflammation, is linked to 3x greater risk of attacks. Although a FeNO test is simple and non-invasive, the test is not yet widely used by HCPs or understood by patients.

Our client briefed us to create an idea that could be implemented in a hospital that would drive home the importance of FeNO for asthma control to both doctors and patients. It was to be piloted in Spain, with scalability for other global markets.

Our Commercial objectives were to elevate understanding and screenings for the FeNO biomarker. Marketing objective was to educate patients who suffer from asthma to better understand their level of risk for an attack, and what the role of inflammation is in their body. Communications objective was to generate awareness in specific regions, across patients and physicians.

Using Data Visualization and Audio Design, the FeNOMENAL experience allows patients to see and hear their asthma risk in a way that inspires them to take action. We correlated individual raw scores to shapes, colors, and sounds that emphasized the lung’s distress. Implemented across the world at hospitals and in clinical settings, FeNOMENAL urges asthma patients with elevated FeNO to talk with their doctor about a plan that could save their life.

The brief was to raise awareness of FeNO in hospital systems, and the expectation was typical advertising. We took the most important aspect of the awareness – an individual’s own score – and created an unforgettable experience that allowed patients and passersby to discover if they were at risk and to become aware, empowered, and ready to take control of their disease.

FeNO scores are overlooked, and not widely understood – but it can provide critical information on a person’s risk of an asthma attack and be a warning sign of harmful inflammation. By having patients take the simple NIOX FeNO text to input their score into the FeNOMENAL experience, they garnered insight that could provide insight into life-changing prevention.

Patient materials complimented the experience to help people understand the meaning of their score, and their level of risk.

We turned the place people with respiratory illness associate most with emergency, to a place where they could proactively take control of their asthma. Hospital lobbies invited passersby to come in and get insight into the pathophysiology of their lungs, find out their level of risk, and be supported by staff and materials for how to approach their doctor. We cannot supply results of data gathered throughout the activation due to patient privacy.

Using custom Data Visualization and Audio Design the FeNOMENAL experience allows patients to see and hear their own risk, in a way that inspires them to take action. Individual raw scores correlated to an algorithm of shapes, colors, and sounds that turned the lung’s distress into a surround sound sensory experience. Patients gained insight into their personal score and saw it mapped against others in their region. FeNOMENAL partnered NIOX, global leader in FeNO testing, with hospitals and advocacy groups across the world to create a new standard of asthma education.

FeNOMENAL kicked off on World Asthma Day and traveled to hospitals in Bilbao, Madrid, Barcelona, and Seville, Spain. After that, it scaled to congresses and preceptorships for HCPs and Patients across Curitiba, Sao Paolo, Brazil; Shanghai, China.

Over 500 patients were tested and hundreds of HCPs are using learning modules designed to educate on the value of FeNO testing.

17% of people who participated in FeNOMENAL events learned they were at risk for an asthma attack. Patients gained insight into their personal score, and were able to see their score mapped against others in their region. FeNOMENAL partnered NIOX, global leader in FeNO testing, with hospitals and advocacy groups across the world to create a new standard for asthma education.and were empowered to talk with their doctor about a plan that could save their life. Globally, more than 257 Million impressions were made across 110 publications.